Vikram Khurana

New discoveries about the role of alpha-synuclein, a well-known protein marker of Parkinson’s, may provide insights for treatment for the disease One of the hallmarks of Parkinson’s disease (PD) is the accumulation in the brain of a protein known as alpha...

HSCI Principal Faculty member Vikram Khurana has received three awards to advance his innovative research on Parkinson’s disease, a neurodegenerative disorder that impacts millions of patients around the world. Khurana is a winner of the “ Ken Griffin...

The 12th annual Business of Regenerative Medicine conference, hosted by the Harvard Stem Cell Institute on 15-16 July 2019, examined how to define and create “value” in a field set to transform human health. At the 12th annual Business of Regenerative...

Vijay Sankaran and Vikram Khurana have been named NYSCF – Robertson Stem Cell Investigators The New York Stem Cell Foundation (NYSCF) has named two HSCI scientists as NYSCF – Robertson Stem Cell Investigators. Vijay Sankaran, M.D., Ph.D. and Vikram...